Cardiovascular Risk, Obesity, and Sociodemographic Indicators in a Brazilian Population

Nayla Cristina do Vale Moreira1,2,3, Ibrahimu Mdala4, Akhtar Hussain2,3,5,6

  • 1Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo (UiO), Oslo, Norway.

Frontiers in Public Health
|December 17, 2021
PubMed

Insights

Cardiovascular disease (CVD) risk is high in Brazil, particularly among men and older adults. Central obesity measures, not just BMI, strongly predict CVD risk, informing prevention strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular diseases (CVDs) are a leading global and Brazilian cause of mortality.
  • Disparities in CVD risk exist across racial/ethnic groups, with limited data on Brazilian populations.
  • Understanding the interplay of sociodemographic factors, obesity, and CVD risk is crucial for public health initiatives.

Purpose of the Study:

  • To evaluate cardiovascular disease (CVD) risk using the Framingham Risk Score in a Brazilian population.
  • To analyze the association between CVD risk and sociodemographic characteristics.
  • To investigate the relationship between anthropometric markers of obesity and predicted CVD risk.

Main Methods:

  • A cross-sectional, population-based survey of 701 adults (≥20 years) in North-eastern Brazil.
  • Assessment of age-adjusted CVD risk (Framingham Risk Score), sociodemographic data, and anthropometric indices.
  • Statistical analysis to examine relationships between variables.

Main Results:

  • 18.9% of the population exhibited high CVD risk (Framingham score ≥10%).
  • Males and older individuals (≥45 years) showed significantly higher CVD risk.
  • Central obesity indicators (waist-to-hip and waist-to-height ratios) were more strongly associated with CVD risk than Body Mass Index (BMI).

Conclusions:

  • The studied Brazilian population presents a substantial burden of cardiovascular disease risk.
  • Central obesity measures are valuable clinical indicators for assessing CVD risk.
  • Targeted, cost-effective screening and prevention strategies are recommended to mitigate CVD impact in Brazil.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
678
Lifestyle Factors and Health01:20

Lifestyle Factors and Health

Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
217
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
10
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
11
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
9
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
5.4K